GLUCOTRACK INC (GCTK) Stock Price, Forecast & Analysis

NASDAQ:GCTK • US45824Q8042

1.6393 USD
-0.01 (-0.65%)
Last: Feb 17, 2026, 09:45 AM

GCTK Key Statistics, Chart & Performance

Key Statistics
Market Cap1.49M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares910.00K
Float860.00K
52 Week High30.51
52 Week Low1.52
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2013-04-09
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
GCTK short term performance overview.The bars show the price performance of GCTK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

GCTK long term performance overview.The bars show the price performance of GCTK in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GCTK is 1.6393 USD. In the past month the price decreased by -58.54%. In the past year, price decreased by -94.39%.

GLUCOTRACK INC / GCTK Daily stock chart

GCTK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
GCTK Full Technical Analysis Report

GCTK Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
GCTK financials

GCTK Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
GCTK Analyst EstimatesGCTK Analyst Ratings

GCTK Ownership

Ownership
Inst Owners1.03%
Ins Owners0.61%
Short Float %27.24%
Short Ratio0.56
GCTK Ownership

GCTK Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.63195.936B
ISRG INTUITIVE SURGICAL INC48.07172.536B
SYK STRYKER CORP24.63139.985B
BSX BOSTON SCIENTIFIC CORP21.78110.826B
IDXX IDEXX LABORATORIES INC42.4550.254B
BDX BECTON DICKINSON AND CO11.350.113B
EW EDWARDS LIFESCIENCES CORP26.744.027B
RMD RESMED INC20.5636.792B
GEHC GE HEALTHCARE TECHNOLOGY16.2636.615B
DXCM DEXCOM INC28.0627.309B

About GCTK

Company Profile

GCTK logo image GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Company Info

GLUCOTRACK INC

301 Rt 17 North, Suite 800

Rutherford NEW JERSEY US

Employees: 11

GCTK Company Website

GCTK Investor Relations

Phone: 197286757878

GLUCOTRACK INC / GCTK FAQ

What does GLUCOTRACK INC do?

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.


What is the current price of GCTK stock?

The current stock price of GCTK is 1.6393 USD. The price decreased by -0.65% in the last trading session.


Does GCTK stock pay dividends?

GCTK does not pay a dividend.


What is the ChartMill rating of GLUCOTRACK INC stock?

GCTK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What sector and industry does GLUCOTRACK INC belong to?

GLUCOTRACK INC (GCTK) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


How many employees does GLUCOTRACK INC have?

GLUCOTRACK INC (GCTK) currently has 11 employees.